SEC Form 4/A · accession 0001209191-17-039253
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert F Apple
Officer — President & CEO · Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 12, 2017 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 7, 2017 | A | 338,115 | $2.66 | A | 1,175,637 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents grant of restricted stock units made under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- F2This amendment is filed solely to correct "D" in Column 4 in the original Form 4 filed on June 9, 2017 to "A."